Advance in clinical research on Antley-Bixler syndrome / 中华医学遗传学杂志
Chinese Journal of Medical Genetics
; (6): 280-283, 2018.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-687959
Responsible library:
WPRO
ABSTRACT
Antley-Bixler syndrome (ABS) is a rare childhood disorder affecting skeletal development. Some patients may also have genital anomalies and impaired steroidogenesis. Diagnostic criteria for ABS has not been fully established, though craniosynostosis, midface hypoplasia and elbow synostosis are minimum requirements. The etiology of ABS is complex, which included autosomal dominant form caused by FGFR2 gene mutations, autosomal recessive form caused by POR gene mutations, and high oral dose of fluconazole during pregnancy. Patients may die from dyspnea due to upper respiratory tract obstruction. This review summarizes research progress on the clinical features, etiology, differential diagnosis, treatment and prevention of ABS.
Full text:
Available
Health context:
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
/
SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5
Health problem:
Target 3.2: Reduce avoidable death in newborns and children under 5
/
Congenital and Chromosomal Anomalies
/
Endocrine System Diseases
/
Neonatal Healthcare
/
Nutrition
Database:
WPRIM (Western Pacific)
Main subject:
Therapeutics
/
Fluconazole
/
Cytochrome P-450 Enzyme System
/
Diagnosis
/
Diagnosis, Differential
/
Receptor, Fibroblast Growth Factor, Type 2
/
Antley-Bixler Syndrome Phenotype
/
Fetus
/
Genetics
Type of study:
Diagnostic study
Limits:
Animals
/
Humans
Language:
Chinese
Journal:
Chinese Journal of Medical Genetics
Year:
2018
Document type:
Article